STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] UiPath, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

UiPath, Inc. (PATH) filed a Form 144 reporting a proposed sale of 1,000,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $12,900,000. The filing states these are founders' shares acquired on 04/21/2021 and indicates the sale is expected on or about 10/06/2025 on the NYSE. The filer represents no undisclosed material information and notes prior Rule 10b5-1 program sales totaling multiple transactions in the past three months, including repeated daily lots of 122,733 shares and several blocks of 45,000 shares, producing gross proceeds listed per trade. The notice identifies total shares outstanding as 453,568,899, which frames the proposed sale as a small fraction of the outstanding base.

Positive

  • Sale size is modest at 1,000,000 shares (~0.22% of outstanding)
  • Seller used Rule 10b5-1 program previously, showing pre-arranged trading activity

Negative

  • Founder share sale could marginally increase free float and selling pressure around 10/06/2025

Insights

TL;DR: A founder sale under Rule 144 is planned and prior 10b5-1 sales were executed recently.

The filing records a proposed sale of $12,900,000 worth of common stock (1,000,000 shares) sourced from founders' shares acquired on 04/21/2021. The transaction is routed through Morgan Stanley Smith Barney LLC and scheduled for 10/06/2025, with trades expected on the NYSE.

Compliance-wise, the notice includes the required representation that the seller is unaware of undisclosed material information and documents a history of Rule 10b5-1 sales in the prior three months. Watch for filings confirming execution details and any updates to the 10b5-1 plan timing within the next few trading days.

TL;DR: Sale size is modest relative to the share base but will increase circulating float slightly.

The proposed 1,000,000-share sale represents roughly 0.22% of the reported 453,568,899 shares outstanding, so the direct dilution or float increase is small in percentage terms. Prior 10b5-1 sales listed show repeated daily lots of 122,733 shares and blocks of 45,000 shares that have already generated multi-million dollar proceeds.

Investors may monitor short-term volume and any further insider dispositions; near-term impact is likely limited given the small percentage of outstanding shares, but execution timing could influence daily trading volumes around 10/06/2025.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does UiPath's (PATH) Form 144 report?

It reports a proposed sale of 1,000,000 common shares valued at $12,900,000, expected on 10/06/2025, through Morgan Stanley Smith Barney LLC on the NYSE.

Are the shares being sold insider or founder shares for PATH?

Yes; the filing lists the securities as founders' shares acquired on 04/21/2021.

How large is the proposed sale versus UiPath's outstanding shares?

The proposed 1,000,000 shares equal about 0.22% of the reported 453,568,899 shares outstanding.

Has there been recent insider selling by this account?

Yes; the filing lists multiple recent Rule 10b5-1 sales in the past three months, including repeated daily lots of 122,733 shares.

Who is the broker handling the sale for PATH?

The broker named is Morgan Stanley Smith Barney LLC, address provided in the filing.
Uipath Inc

NYSE:PATH

PATH Rankings

PATH Latest News

PATH Latest SEC Filings

PATH Stock Data

6.91B
415.64M
9.44%
82.2%
10.47%
Software - Infrastructure
Services-prepackaged Software
Link
United States
NEW YORK